acarbose

RxCUI 16681 ingredient

Contraindicated with · 30

Diagnoses12

Diabetic Ketoacidosis Ketosis Liver Cirrhosis Acidosis Fibrosis Acid-Base Imbalance Colitis, Ulcerative Colitis Intestinal Obstruction Diabetes Mellitus Gastroenteritis Drug Hypersensitivity

Condition families18

Digestive System Abnormalities Malabsorption Syndromes Diabetes Complications Inflammatory Bowel Diseases Congenital Abnormalities Colonic Diseases Liver Diseases Endocrine System Diseases Intestinal Diseases Congenital, Hereditary, and Neonatal Diseases and Abnormalities Gastrointestinal Diseases Metabolic Diseases Nutritional and Metabolic Diseases Digestive System Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Drug-Related Side Effects and Adverse Reactions Chemically-Induced Disorders

Indicated for · 6

Diagnoses2

Diabetes Mellitus, Type 2 Diabetes Mellitus

Condition families4

Glucose Metabolism Disorders Endocrine System Diseases Metabolic Diseases Nutritional and Metabolic Diseases

MED-RT, published by the VA through NLM. Relationships attach at the ingredient level, not to a specific product or dose.

RADV audits Coding jobs Chart counter Hours & decimal time About Contact Help Terms Privacy

Innova Coding Suite extension — both tools in your browser: Add to Chrome · Add to Edge

InnovaRx — Innova Health Strategies. ICD-10-CM and the CMS-HCC risk adjustment models are published by CMS and NCHS and are in the public domain. Effective date 2026-10-22 travels in the URL, so this link shows anyone exactly what you see.